2024-03-01 2025-02-28 2025-02-28 false 13230371 BRIDGING THE GAP FOR HEALTH PRACTITIONERS LIMITED 2025-06-10 85600 false iso4217:GBP xbrli:pure 13230371 2024-02-29 13230371 2025-02-28 13230371 2024-03-01 2025-02-28 13230371 2023-02-28 13230371 2024-02-29 13230371 2023-03-01 2024-02-29 13230371 bus:SmallEntities 2024-03-01 2025-02-28 13230371 bus:AuditExempt-NoAccountantsReport 2024-03-01 2025-02-28 13230371 bus:FullAccounts 2024-03-01 2025-02-28 13230371 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 13230371 core:WithinOneYear 2025-02-28 13230371 core:AfterOneYear 2025-02-28 13230371 core:WithinOneYear 2024-02-29 13230371 core:AfterOneYear 2024-02-29 13230371 core:ShareCapital 2025-02-28 13230371 core:SharePremium 2025-02-28 13230371 core:RevaluationReserve 2025-02-28 13230371 core:OtherReservesSubtotal 2025-02-28 13230371 core:RetainedEarningsAccumulatedLosses 2025-02-28 13230371 core:ShareCapital 2024-02-29 13230371 core:SharePremium 2024-02-29 13230371 core:RevaluationReserve 2024-02-29 13230371 core:OtherReservesSubtotal 2024-02-29 13230371 core:RetainedEarningsAccumulatedLosses 2024-02-29 13230371 core:LandBuildings 2025-02-28 13230371 core:PlantMachinery 2025-02-28 13230371 core:Vehicles 2025-02-28 13230371 core:FurnitureFittings 2025-02-28 13230371 core:OfficeEquipment 2025-02-28 13230371 core:NetGoodwill 2025-02-28 13230371 core:IntangibleAssetsOtherThanGoodwill 2025-02-28 13230371 core:ListedExchangeTraded 2025-02-28 13230371 core:UnlistedNon-exchangeTraded 2025-02-28 13230371 core:LandBuildings 2024-02-29 13230371 core:PlantMachinery 2024-02-29 13230371 core:Vehicles 2024-02-29 13230371 core:FurnitureFittings 2024-02-29 13230371 core:OfficeEquipment 2024-02-29 13230371 core:NetGoodwill 2024-02-29 13230371 core:IntangibleAssetsOtherThanGoodwill 2024-02-29 13230371 core:ListedExchangeTraded 2024-02-29 13230371 core:UnlistedNon-exchangeTraded 2024-02-29 13230371 core:LandBuildings 2024-03-01 2025-02-28 13230371 core:PlantMachinery 2024-03-01 2025-02-28 13230371 core:Vehicles 2024-03-01 2025-02-28 13230371 core:FurnitureFittings 2024-03-01 2025-02-28 13230371 core:OfficeEquipment 2024-03-01 2025-02-28 13230371 core:NetGoodwill 2024-03-01 2025-02-28 13230371 core:IntangibleAssetsOtherThanGoodwill 2024-03-01 2025-02-28 13230371 core:ListedExchangeTraded 2024-03-01 2025-02-28 13230371 core:UnlistedNon-exchangeTraded 2024-03-01 2025-02-28 13230371 core:MoreThanFiveYears 2024-03-01 2025-02-28 13230371 core:Non-currentFinancialInstruments 2025-02-28 13230371 core:Non-currentFinancialInstruments 2024-02-29 13230371 dpl:CostSales 2024-03-01 2025-02-28 13230371 dpl:DistributionCosts 2024-03-01 2025-02-28 13230371 core:LandBuildings 2024-03-01 2025-02-28 13230371 core:PlantMachinery 2024-03-01 2025-02-28 13230371 core:Vehicles 2024-03-01 2025-02-28 13230371 core:FurnitureFittings 2024-03-01 2025-02-28 13230371 core:OfficeEquipment 2024-03-01 2025-02-28 13230371 dpl:AdministrativeExpenses 2024-03-01 2025-02-28 13230371 core:NetGoodwill 2024-03-01 2025-02-28 13230371 core:IntangibleAssetsOtherThanGoodwill 2024-03-01 2025-02-28 13230371 dpl:GroupUndertakings 2024-03-01 2025-02-28 13230371 dpl:ParticipatingInterests 2024-03-01 2025-02-28 13230371 dpl:GroupUndertakings core:ListedExchangeTraded 2024-03-01 2025-02-28 13230371 core:ListedExchangeTraded 2024-03-01 2025-02-28 13230371 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-03-01 2025-02-28 13230371 core:UnlistedNon-exchangeTraded 2024-03-01 2025-02-28 13230371 dpl:CostSales 2023-03-01 2024-02-29 13230371 dpl:DistributionCosts 2023-03-01 2024-02-29 13230371 core:LandBuildings 2023-03-01 2024-02-29 13230371 core:PlantMachinery 2023-03-01 2024-02-29 13230371 core:Vehicles 2023-03-01 2024-02-29 13230371 core:FurnitureFittings 2023-03-01 2024-02-29 13230371 core:OfficeEquipment 2023-03-01 2024-02-29 13230371 dpl:AdministrativeExpenses 2023-03-01 2024-02-29 13230371 core:NetGoodwill 2023-03-01 2024-02-29 13230371 core:IntangibleAssetsOtherThanGoodwill 2023-03-01 2024-02-29 13230371 dpl:GroupUndertakings 2023-03-01 2024-02-29 13230371 dpl:ParticipatingInterests 2023-03-01 2024-02-29 13230371 dpl:GroupUndertakings core:ListedExchangeTraded 2023-03-01 2024-02-29 13230371 core:ListedExchangeTraded 2023-03-01 2024-02-29 13230371 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-03-01 2024-02-29 13230371 core:UnlistedNon-exchangeTraded 2023-03-01 2024-02-29 13230371 core:NetGoodwill 2025-02-28 13230371 core:IntangibleAssetsOtherThanGoodwill 2025-02-28 13230371 core:LandBuildings 2025-02-28 13230371 core:PlantMachinery 2025-02-28 13230371 core:Vehicles 2025-02-28 13230371 core:FurnitureFittings 2025-02-28 13230371 core:OfficeEquipment 2025-02-28 13230371 core:AfterOneYear 2025-02-28 13230371 core:WithinOneYear 2025-02-28 13230371 core:ListedExchangeTraded 2025-02-28 13230371 core:UnlistedNon-exchangeTraded 2025-02-28 13230371 core:ShareCapital 2025-02-28 13230371 core:SharePremium 2025-02-28 13230371 core:RevaluationReserve 2025-02-28 13230371 core:OtherReservesSubtotal 2025-02-28 13230371 core:RetainedEarningsAccumulatedLosses 2025-02-28 13230371 core:NetGoodwill 2024-02-29 13230371 core:IntangibleAssetsOtherThanGoodwill 2024-02-29 13230371 core:LandBuildings 2024-02-29 13230371 core:PlantMachinery 2024-02-29 13230371 core:Vehicles 2024-02-29 13230371 core:FurnitureFittings 2024-02-29 13230371 core:OfficeEquipment 2024-02-29 13230371 core:AfterOneYear 2024-02-29 13230371 core:WithinOneYear 2024-02-29 13230371 core:ListedExchangeTraded 2024-02-29 13230371 core:UnlistedNon-exchangeTraded 2024-02-29 13230371 core:ShareCapital 2024-02-29 13230371 core:SharePremium 2024-02-29 13230371 core:RevaluationReserve 2024-02-29 13230371 core:OtherReservesSubtotal 2024-02-29 13230371 core:RetainedEarningsAccumulatedLosses 2024-02-29 13230371 core:NetGoodwill 2023-02-28 13230371 core:IntangibleAssetsOtherThanGoodwill 2023-02-28 13230371 core:LandBuildings 2023-02-28 13230371 core:PlantMachinery 2023-02-28 13230371 core:Vehicles 2023-02-28 13230371 core:FurnitureFittings 2023-02-28 13230371 core:OfficeEquipment 2023-02-28 13230371 core:AfterOneYear 2023-02-28 13230371 core:WithinOneYear 2023-02-28 13230371 core:ListedExchangeTraded 2023-02-28 13230371 core:UnlistedNon-exchangeTraded 2023-02-28 13230371 core:ShareCapital 2023-02-28 13230371 core:SharePremium 2023-02-28 13230371 core:RevaluationReserve 2023-02-28 13230371 core:OtherReservesSubtotal 2023-02-28 13230371 core:RetainedEarningsAccumulatedLosses 2023-02-28 13230371 core:AfterOneYear 2024-03-01 2025-02-28 13230371 core:WithinOneYear 2024-03-01 2025-02-28 13230371 core:Non-currentFinancialInstruments core:CostValuation 2024-03-01 2025-02-28 13230371 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-03-01 2025-02-28 13230371 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-03-01 2025-02-28 13230371 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-03-01 2025-02-28 13230371 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-03-01 2025-02-28 13230371 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-03-01 2025-02-28 13230371 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-03-01 2025-02-28 13230371 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-03-01 2025-02-28 13230371 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-03-01 2025-02-28 13230371 core:Non-currentFinancialInstruments core:CostValuation 2025-02-28 13230371 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-02-28 13230371 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-02-28 13230371 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-02-28 13230371 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-02-28 13230371 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-02-28 13230371 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-02-28 13230371 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-02-28 13230371 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-02-28 13230371 core:Non-currentFinancialInstruments core:CostValuation 2024-02-29 13230371 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-02-29 13230371 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-02-29 13230371 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-02-29 13230371 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-02-29 13230371 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-02-29 13230371 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-02-29 13230371 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-02-29 13230371 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-02-29 13230371 bus:Director1 2024-03-01 2025-02-28

BRIDGING THE GAP FOR HEALTH PRACTITIONERS LIMITED

Registered Number
13230371
(England and Wales)

Unaudited Financial Statements for the Year ended
28 February 2025

BRIDGING THE GAP FOR HEALTH PRACTITIONERS LIMITED
Company Information
for the year from 1 March 2024 to 28 February 2025

Director | Gabrielle Forrester

Registered Address | 179 Park Lane
| Poynton
| SK12 1RH

Registered Number | 13230371 (England and Wales)

BRIDGING THE GAP FOR HEALTH PRACTITIONERS LIMITED
Balance Sheet as at
28 February 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 1,272 |  |  |  | 1,590
|  |  |  | 1,272 |  |  |  | 1,590
Current assets |  |  |  |  |  |  |  |
Debtors | 4 | 32 |  |  |  | 2 |  |
Cash at bank and on hand |  | 14,101 |  |  |  | 8,888 |  |
|  | 14,133 |  |  |  | 8,890 |  |
Creditors amounts falling due within one year | 5 | (12,389) |  |  |  | (11,997) |  |
Net current assets (liabilities) |  |  |  | 1,744 |  |  |  | (3,107)
Total assets less current liabilities |  |  |  | 3,016 |  |  |  | (1,517)
Net assets |  |  |  | 3,016 |  |  |  | (1,517)
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 100 |  |  |  | 100
Profit and loss account |  |  |  | 2,916 |  |  |  | (1,617)
Shareholders' funds |  |  |  | 3,016 |  |  |  | (1,517)

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 10 June 2025, and are signed on its behalf by:
Gabrielle Forrester Director Registered Company No. 13230371

BRIDGING THE GAP FOR HEALTH PRACTITIONERS LIMITED
Notes to the Financial Statements
for the year ended 28 February 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Going concern
--- | ---
| After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.

| Judgements and key sources of estimation uncertainty
--- | ---
| In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

| Revenue from sale of goods
--- | ---
| Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Current taxation
--- | ---
| Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

| Tangible fixed assets and depreciation
--- | ---
| Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

|  | Reducing balance (%)
| Office Equipment | 20

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 1 |  | 1

3. | Tangible fixed assets
--- | ---

|  | Office Equipment |  | Total
--- | --- | --- | --- | ---
|  | £ |  | £
| Cost or valuation
| At 01 March 24 | 1,966 |  | 1,966
| At 28 February 25 | 1,966 |  | 1,966
| Depreciation and impairment
| At 01 March 24 | 376 |  | 376
| Charge for year | 318 |  | 318
| At 28 February 25 | 694 |  | 694
| Net book value
| At 28 February 25 | 1,272 |  | 1,272
| At 29 February 24 | 1,590 |  | 1,590

4. | Debtors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Other debtors | 32 |  | 2
| Total | 32 |  | 2

| Short term trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts.

5. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Taxation and social security | 6,767 |  | 5,200
| Other creditors | 5,622 |  | 6,797
| Total | 12,389 |  | 11,997

| Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.